{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:54:57Z","timestamp":1791417297826,"version":"4.3.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The proximal tubule (PT) reabsorbs most of the glomerular filtrate and plays an important role in the uptake, metabolism and excretion of xenobiotics. Some therapeutic drugs are harmful to the PT, and resulting nephrotoxicity is thought to be responsible for approximately 1 in 6 of cases of children hospitalized with acute kidney injury (AKI). Clinically, PT dysfunction leads to urinary wasting of important solutes normally reabsorbed by this nephron segment, leading to systemic complications such as bone demineralization and a clinical scenario known as the renal Fanconi syndrome (RFS). While PT defects can be diagnosed using a combination of blood and urine markers, including urinary excretion of low molecular weight proteins (LMWP), standardized definitions of what constitutes clinically significant toxicity are lacking, and identifying which patients will go on to develop progressive loss of kidney function remains a major challenge. In addition, much of our understanding of cellular mechanisms of drug toxicity is still limited, partly due to the constraints of available cell and animal models. However, advances in new and more sophisticated in vitro models of the PT, along with the application of high-content analytical methods that can provide readouts more relevant to the clinical manifestations of nephrotoxicity, are beginning to extend our knowledge. Such technical progress should help in discovering new biomarkers that can better detect nephrotoxicity earlier and predict its long-term consequences, and herald a new era of more personalized medicine.<\/jats:p>","DOI":"10.1007\/s00467-021-05121-9","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T19:02:56Z","timestamp":1622228576000},"page":"973-982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Drug toxicity in the proximal tubule: new models, methods and mechanisms"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6328-7892","authenticated-orcid":false,"given":"Andrew M.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trepiccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"5121_CR1","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-013-2666-6","volume":"30","author":"J Gattineni","year":"2015","unstructured":"Gattineni J, Baum M (2015) Developmental changes in renal tubular transport\u2014an overview. Pediatr Nephrol 30:2085\u20132098. https:\/\/doi.org\/10.1007\/s00467-013-2666-6","journal-title":"Pediatr Nephrol"},{"key":"5121_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-642-61105-6_17","volume":"18","author":"W Dekant","year":"1996","unstructured":"Dekant W (1996) Biotransformation and renal processing of nephrotoxic agents. Arch Toxicol Suppl 18:163\u2013172","journal-title":"Arch Toxicol Suppl"},{"key":"5121_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000092212","volume":"103","author":"V Launay-Vacher","year":"2006","unstructured":"Launay-Vacher V, Izzedine H, Karie S, Hulot JS et al (2006) Renal tubular drug transporters. Nephron Physiol 103:97\u2013106","journal-title":"Nephron Physiol"},{"key":"5121_CR4","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2215\/CJN.02440314","volume":"10","author":"SK Nigam","year":"2015","unstructured":"Nigam SK, Wu W, Bush KT, Hoenig MP et al (2015) Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters. Clin J Am Soc Nephrol 10:2039\u20132049. https:\/\/doi.org\/10.2215\/CJN.02440314","journal-title":"Clin J Am Soc Nephrol"},{"key":"5121_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/cphy.c100073","volume":"2","author":"EI Christensen","year":"2012","unstructured":"Christensen EI, Wagner CA, Kaissling B (2012) Uriniferous tubule: structural and functional organization. Compr Physiol 2:805\u2013861. https:\/\/doi.org\/10.1002\/cphy.c100073","journal-title":"Compr Physiol"},{"key":"5121_CR6","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1681\/ASN.2018050522","volume":"29","author":"CD Schuh","year":"2018","unstructured":"Schuh CD, Polesel M, Platonova E, Haenni D et al (2018) Combined structural and functional imaging of the kidney reveals major axial differences in proximal tubule endocytosis. J Am Soc Nephrol 29:2696\u20132712. https:\/\/doi.org\/10.1681\/ASN.2018050522","journal-title":"J Am Soc Nephrol"},{"key":"5121_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MCC.0000000000000653","volume":"25","author":"MA Perazella","year":"2019","unstructured":"Perazella MA (2019) Drug-induced acute kidney injury: diverse mechanisms of tubular injury. Curr Opin Crit Care 25:550\u2013557","journal-title":"Curr Opin Crit Care"},{"key":"5121_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","volume":"41","author":"H Izzedine","year":"2003","unstructured":"Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G (2003) Drug-induced Fanconi\u2019s syndrome. Am J Kidney Dis 41:292\u2013309","journal-title":"Am J Kidney Dis"},{"key":"5121_CR9","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2215\/CJN.02050309","volume":"4","author":"MA Perazella","year":"2009","unstructured":"Perazella MA (2009) Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4:1275\u20131283","journal-title":"Clin J Am Soc Nephrol"},{"key":"5121_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ (2014) Drug-induced renal Fanconi syndrome. QJM 107:261\u2013269","journal-title":"QJM"},{"key":"5121_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2215\/CJN.00150118","volume":"13","author":"MA Perazella","year":"2018","unstructured":"Perazella MA (2018) Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol 13:1897\u20131908. https:\/\/doi.org\/10.2215\/CJN.00150118","journal-title":"Clin J Am Soc Nephrol"},{"key":"5121_CR12","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1111\/bcp.13388","volume":"83","author":"A Ruggiero","year":"2017","unstructured":"Ruggiero A, Ferrara P, Attin\u00e0 G, Rizzo D et al (2017) Renal toxicity and chemotherapy in children with cancer. Br J Clin Pharmacol 83:2605\u20132614. https:\/\/doi.org\/10.1111\/bcp.13388","journal-title":"Br J Clin Pharmacol"},{"key":"5121_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/INF.0000000000000571","volume":"34","author":"L Aurpibul","year":"2015","unstructured":"Aurpibul L, Puthanakit T (2015) Review of tenofovir use in HIV-infected children. Pediatr Infect Dis J 34:383\u2013391. https:\/\/doi.org\/10.1097\/INF.0000000000000571","journal-title":"Pediatr Infect Dis J"},{"key":"5121_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/INF.0000000000000289","volume":"34","author":"X Saez-Llorens","year":"2015","unstructured":"Saez-Llorens X, Casta\u00f1o E, Rathore M, Church J et al (2015) A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression. Pediatr Infect Dis J 34:376\u2013382. https:\/\/doi.org\/10.1097\/INF.0000000000000289","journal-title":"Pediatr Infect Dis J"},{"key":"5121_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","volume":"23","author":"P Labarga","year":"2009","unstructured":"Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S et al (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 23:689\u2013696. https:\/\/doi.org\/10.1097\/QAD.0b013e3283262a64","journal-title":"AIDS"},{"key":"5121_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nbt.1625","volume":"28","author":"F Dieterle","year":"2010","unstructured":"Dieterle F, Sistare F, Goodsaid F, Papaluca M et al (2010) Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 28:455\u2013462","journal-title":"Nat Biotechnol"},{"key":"5121_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/460208a","volume":"460","author":"T Hartung","year":"2009","unstructured":"Hartung T (2009) Toxicology for the twenty-first century. Nature 460:208\u2013212","journal-title":"Nature"},{"key":"5121_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1681\/ASN.2020060849","volume":"32","author":"DM Green","year":"2021","unstructured":"Green DM, Wang M, Krasin M, Srivastava D et al (2021) Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime Cohort Study. J Am Soc Nephrol 32:983\u2013993. https:\/\/doi.org\/10.1681\/ASN.2020060849","journal-title":"J Am Soc Nephrol"},{"key":"5121_CR19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/ndt\/gfu377","volume":"30","author":"ED Klootwijk","year":"2015","unstructured":"Klootwijk ED, Reichold M, Unwin RJ, Kleta R et al (2015) Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrol Dial Transplant 30:1456\u20131460","journal-title":"Nephrol Dial Transplant"},{"key":"5121_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00689694","volume":"28","author":"R Skinner","year":"1991","unstructured":"Skinner R, Pearson ADJ, Coulthard MG, Skillen AW et al (1991) Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemother Pharmacol 28:81\u201392","journal-title":"Cancer Chemother Pharmacol"},{"key":"5121_CR21","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1097\/QAD.0b013e32834bba87","volume":"25","author":"SME Vrouenraets","year":"2011","unstructured":"Vrouenraets SME, Fux CA, Wit FWNM, Garcia EF et al (2011) Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity. AIDS 25:2149\u20132155. https:\/\/doi.org\/10.1097\/QAD.0b013e32834bba87","journal-title":"AIDS"},{"key":"5121_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.07.012","volume":"54","author":"AM Hall","year":"2009","unstructured":"Hall AM, Edwards SG, Lapsley M, O Connolly J et al (2009) Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis 54:1034\u20131042. https:\/\/doi.org\/10.1053\/j.ajkd.2009.07.012","journal-title":"Am J Kidney Dis"},{"key":"5121_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/000456329803500116","volume":"35","author":"M Lapsley","year":"1998","unstructured":"Lapsley M, Akers K, Norden AGW (1998) Sensitive assays for urinary retinol-binding protein and \u03b2-2-glycoprotein-1 based on commercially available standards. Ann Clin Biochem 35:115\u2013119. https:\/\/doi.org\/10.1177\/000456329803500116","journal-title":"Ann Clin Biochem"},{"key":"5121_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1523-1755.2000.00847.x","volume":"57","author":"AGW Norden","year":"2000","unstructured":"Norden AGW, Scheinman SJ, Deschodt-Lanckman MM, Lapsey M et al (2000) Tubular proteinuria defined by a study of Dent\u2019s (CLCN5 mutation) and other tubular diseases. Kidney Int 57:240\u2013249. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00847.x","journal-title":"Kidney Int"},{"key":"5121_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","volume":"10","author":"CLN Woodward","year":"2009","unstructured":"Woodward CLN, Hall AM, Williams IG, Madge S et al (2009) Tenofovir-associated renal and bone toxicity. HIV Med 10:482\u2013487. https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00716.x","journal-title":"HIV Med"},{"key":"5121_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/cts.12481","volume":"10","author":"A Chapron","year":"2017","unstructured":"Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C et al (2017) Does secretory clearance follow glomerular filtration rate in chronic kidney diseases? Reconsidering the intact nephron hypothesis. Clin Transl Sci 10:395\u2013403. https:\/\/doi.org\/10.1111\/cts.12481","journal-title":"Clin Transl Sci"},{"key":"5121_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/ki.2010.318","volume":"78","author":"LC Herlitz","year":"2010","unstructured":"Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J et al (2010) Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 78:1171\u20131177. https:\/\/doi.org\/10.1038\/ki.2010.318","journal-title":"Kidney Int"},{"key":"5121_CR28","first-page":"924","volume":"32","author":"J Ma\u0142yszko","year":"2017","unstructured":"Ma\u0142yszko J, Koz\u0142owska K, Koz\u0142owski L, Ma\u0142yszko J (2017) Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant 32:924\u2013936","journal-title":"Nephrol Dial Transplant"},{"key":"5121_CR29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jpeds.2012.11.069","volume":"162","author":"JM Misurac","year":"2013","unstructured":"Misurac JM, Knoderer CA, Leiser JD, Nailescu C et al (2013) Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr 162:1153\u20131159.e1","journal-title":"J Pediatr"},{"key":"5121_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1203\/PDR.0b013e318123f6e3","volume":"62","author":"AL Kent","year":"2007","unstructured":"Kent AL, Maxwell LE, Koina ME, Falk MC et al (2007) Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62:307\u2013312. https:\/\/doi.org\/10.1203\/PDR.0b013e318123f6e3","journal-title":"Pediatr Res"},{"key":"5121_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00467-004-1807-3","volume":"20","author":"K Aleksa","year":"2005","unstructured":"Aleksa K, Matsell D, Krausz K, Gelboin H et al (2005) Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity. Pediatr Nephrol 20:872\u2013885. https:\/\/doi.org\/10.1007\/s00467-004-1807-3","journal-title":"Pediatr Nephrol"},{"key":"5121_CR32","doi-asserted-by":"publisher","first-page":"F522","DOI":"10.1152\/ajprenal.1985.248.4.F522","volume":"248","author":"S Bagnasco","year":"1985","unstructured":"Bagnasco S, Good D, Balaban R, Burg M (1985) Lactate production in isolated segments of the rat nephron. Am J Phys 248:F522\u2013F526. https:\/\/doi.org\/10.1152\/ajprenal.1985.248.4.F522","journal-title":"Am J Phys"},{"key":"5121_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nrneph.2009.97","volume":"5","author":"V Sahni","year":"2009","unstructured":"Sahni V, Choudhury D, Ahmed Z (2009) Chemotherapy-associated renal dysfunction. Nat Rev Nephrol 5:450\u2013462","journal-title":"Nat Rev Nephrol"},{"key":"5121_CR34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","volume":"30","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Moeckel GW (2010) Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention\/therapy. Semin Nephrol 30:570\u2013581. https:\/\/doi.org\/10.1016\/j.semnephrol.2010.09.005","journal-title":"Semin Nephrol"},{"key":"5121_CR35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41467-021-21714-2","volume":"12","author":"Q Weng","year":"2021","unstructured":"Weng Q, Sun H, Fang C, Xia F et al (2021) Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics. Nat Commun 12:1436. https:\/\/doi.org\/10.1038\/s41467-021-21714-2","journal-title":"Nat Commun"},{"key":"5121_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook D, Brown D, Alexander R, March R et al (2014) Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov 13:419\u2013431","journal-title":"Nat Rev Drug Discov"},{"key":"5121_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.taap.2009.11.019","volume":"243","author":"RD Beger","year":"2010","unstructured":"Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243:154\u2013166. https:\/\/doi.org\/10.1016\/j.taap.2009.11.019","journal-title":"Toxicol Appl Pharmacol"},{"key":"5121_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12011-015-0339-y","volume":"166","author":"BR Simon-Friedt","year":"2015","unstructured":"Simon-Friedt BR, Wilson MJ, Blake DA, Yu H et al (2015) The RPTEC\/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments. Biol Trace Elem Res 166:66\u201371. https:\/\/doi.org\/10.1007\/s12011-015-0339-y","journal-title":"Biol Trace Elem Res"},{"key":"5121_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/toxsci\/kfs279","volume":"131","author":"RT Naven","year":"2013","unstructured":"Naven RT, Swiss R, Klug-Mcleod J, Will Y et al (2013) The development of structure-activity relationships for mitochondrial dysfunction: uncoupling of oxidative phosphorylation. Toxicol Sci 131:271\u2013278. https:\/\/doi.org\/10.1093\/toxsci\/kfs279","journal-title":"Toxicol Sci"},{"key":"5121_CR40","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s00204-015-1638-y","volume":"90","author":"R Su","year":"2016","unstructured":"Su R, Xiong S, Zink D, Loo LH (2016) High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures. Arch Toxicol 90:2793\u20132808. https:\/\/doi.org\/10.1007\/s00204-015-1638-y","journal-title":"Arch Toxicol"},{"key":"5121_CR41","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s00204-018-2284-y","volume":"92","author":"AK Sj\u00f6gren","year":"2018","unstructured":"Sj\u00f6gren AK, Breitholtz K, Ahlberg E, Milton L et al (2018) A novel multi-parametric high content screening assay in ciPTEC-OAT1 to predict drug-induced nephrotoxicity during drug discovery. Arch Toxicol 92:3175\u20133190. https:\/\/doi.org\/10.1007\/s00204-018-2284-y","journal-title":"Arch Toxicol"},{"key":"5121_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tiv.2014.10.006","volume":"30","author":"A Wilmes","year":"2015","unstructured":"Wilmes A, Bielow C, Ranninger C, Bellwon P et al (2015) Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol in Vitro 30:117\u2013127. https:\/\/doi.org\/10.1016\/j.tiv.2014.10.006","journal-title":"Toxicol in Vitro"},{"key":"5121_CR43","doi-asserted-by":"publisher","first-page":"eabd6299","DOI":"10.1126\/scitranslmed.abd6299","volume":"13","author":"A Cohen","year":"2021","unstructured":"Cohen A, Ioannidis K, Ehrlich A, Regenbaum S et al (2021) Mechanism and reversal of drug-induced nephrotoxicity on a chip. Sci Transl Med 13:eabd6299. https:\/\/doi.org\/10.1126\/scitranslmed.abd6299","journal-title":"Sci Transl Med"},{"key":"5121_CR44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41598-020-58386-9","volume":"10","author":"EM Gottwald","year":"2020","unstructured":"Gottwald EM, Schuh CD, Dr\u00fccker P, Haenni D et al (2020) The iron chelator deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on inner membrane permeability. Sci Rep 10:1577. https:\/\/doi.org\/10.1038\/s41598-020-58386-9","journal-title":"Sci Rep"},{"key":"5121_CR45","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00467-012-2170-4","volume":"27","author":"L Dubourg","year":"2012","unstructured":"Dubourg L, Laurain C, Ranchin B, Pondarr\u00e9 C et al (2012) Deferasirox-induced renal impairment in children: an increasing concern for pediatricians. Pediatr Nephrol 27:2115\u20132122. https:\/\/doi.org\/10.1007\/s00467-012-2170-4","journal-title":"Pediatr Nephrol"},{"key":"5121_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nrneph.2014.121","volume":"10","author":"JD D\u00edaz-Garc\u00eda","year":"2014","unstructured":"D\u00edaz-Garc\u00eda JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni\u00f1o MD et al (2014) Deferasirox nephrotoxicity\u2014the knowns and unknowns. Nat Rev Nephrol 10:574\u2013586","journal-title":"Nat Rev Nephrol"},{"key":"5121_CR47","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2215\/CJN.01430219","volume":"14","author":"AM Hall","year":"2019","unstructured":"Hall AM, Unwin RJ (2019) A case of drug-induced proximal tubular dysfunction. Clin J Am Soc Nephrol 14:1384\u20131387. https:\/\/doi.org\/10.2215\/CJN.01430219","journal-title":"Clin J Am Soc Nephrol"},{"key":"5121_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1152\/physrev.1986.66.2.469","volume":"66","author":"G Wirthensohn","year":"1986","unstructured":"Wirthensohn G, Guder WG (1986) Renal substrate metabolism. Physiol Rev 66:469\u2013497","journal-title":"Physiol Rev"},{"key":"5121_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/1389200219666180119115133","volume":"19","author":"E Gozalpour","year":"2018","unstructured":"Gozalpour E, Fenner KS (2018) Current state of in vitro cell-based renal models. Curr Drug Metab 19:310\u2013326. https:\/\/doi.org\/10.2174\/1389200219666180119115133","journal-title":"Curr Drug Metab"},{"key":"5121_CR50","doi-asserted-by":"publisher","unstructured":"Punt A (2020) New approach methodologies (NAMs) for human-relevant biokinetics predictions. ALTEX. https:\/\/doi.org\/10.14573\/altex.2003242","DOI":"10.14573\/altex.2003242"},{"key":"5121_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tiv.2014.12.003","volume":"30","author":"L Aschauer","year":"2015","unstructured":"Aschauer L, Carta G, Vogelsang N, Schlatter E et al (2015) Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1. Toxicol in Vitro 30:95\u2013105. https:\/\/doi.org\/10.1016\/j.tiv.2014.12.003","journal-title":"Toxicol in Vitro"},{"key":"5121_CR52","doi-asserted-by":"publisher","first-page":"152535","DOI":"10.1016\/j.tox.2020.152535","volume":"442","author":"P Bajaj","year":"2020","unstructured":"Bajaj P, Chung G, Pye K, Yukawa T et al (2020) Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity. Toxicology 442:152535. https:\/\/doi.org\/10.1016\/j.tox.2020.152535","journal-title":"Toxicology"},{"key":"5121_CR53","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/ncb3437","volume":"18","author":"MM Kaminski","year":"2016","unstructured":"Kaminski MM, Tosic J, Kresbach C, Engel H et al (2016) Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors. Nat Cell Biol 18:1269\u20131280. https:\/\/doi.org\/10.1038\/ncb3437","journal-title":"Nat Cell Biol"},{"key":"5121_CR54","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00597.2019","volume":"318","author":"JLM Digby","year":"2020","unstructured":"Digby JLM, Vanichapol T, Przepiorski A, Davidson AJ et al (2020) Evaluation of cisplatin-induced injury in human kidney organoids. Am J Physiol Renal Physiol 318:F971\u2013F978. https:\/\/doi.org\/10.1152\/ajprenal.00597.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"5121_CR55","doi-asserted-by":"publisher","first-page":"17610","DOI":"10.1038\/s41598-019-53855-2","volume":"9","author":"HM Kang","year":"2019","unstructured":"Kang HM, Lim JH, Noh KH, Park D et al (2019) Effective reconstruction of functional organotypic kidney spheroid for in vitro nephrotoxicity studies. Sci Rep 9:17610. https:\/\/doi.org\/10.1038\/s41598-019-53855-2","journal-title":"Sci Rep"},{"key":"5121_CR56","doi-asserted-by":"publisher","first-page":"e0184330","DOI":"10.1371\/journal.pone.0184330","volume":"12","author":"EM Vedula","year":"2017","unstructured":"Vedula EM, Alonso JL, Arnaout MA, Charest JL (2017) A microfluidic renal proximal tubule with active reabsorptive function. PLoS One 12:e0184330. https:\/\/doi.org\/10.1371\/journal.pone.0184330","journal-title":"PLoS One"},{"key":"5121_CR57","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.kint.2018.06.034","volume":"94","author":"N Ashammakhi","year":"2018","unstructured":"Ashammakhi N, Wesseling-Perry K, Hasan A, Elkhammas E et al (2018) Kidney-on-a-chip: untapped opportunities. Kidney Int 94:1073\u20131086","journal-title":"Kidney Int"},{"key":"5121_CR58","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1091\/mbc.E17-04-0211","volume":"28","author":"KR Long","year":"2017","unstructured":"Long KR, Shipman KE, Rbaibi Y, Menshikova EV et al (2017) Proximal tubule apical endocytosis is modulated by fluid shear stress via an mTOR-dependent pathway. Mol Biol Cell 28:2508\u20132517. https:\/\/doi.org\/10.1091\/mbc.E17-04-0211","journal-title":"Mol Biol Cell"},{"key":"5121_CR59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/tra.12648","volume":"20","author":"Q Ren","year":"2019","unstructured":"Ren Q, Gliozzi ML, Rittenhouse NL, Edmunds LR et al (2019) Shear stress and oxygen availability drive differential changes in opossum kidney proximal tubule cell metabolism and endocytosis. Traffic 20:448\u2013459. https:\/\/doi.org\/10.1111\/tra.12648","journal-title":"Traffic"},{"key":"5121_CR60","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1039\/c5lc00392j","volume":"15","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T et al (2015) A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15:2688\u20132699. https:\/\/doi.org\/10.1039\/c5lc00392j","journal-title":"Lab Chip"},{"key":"5121_CR61","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.kint.2019.11.016","volume":"97","author":"Z Chen","year":"2020","unstructured":"Chen Z, Luciani A, Mateos JM, Barmettler G et al (2020) Transgenic zebrafish modeling low-molecular-weight proteinuria and lysosomal storage diseases. Kidney Int 97:1150\u20131163. https:\/\/doi.org\/10.1016\/j.kint.2019.11.016","journal-title":"Kidney Int"},{"key":"5121_CR62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12882-017-0536-3","volume":"18","author":"L Awdishu","year":"2017","unstructured":"Awdishu L, Mehta RL (2017) The 6R\u2019s of drug induced nephrotoxicity. BMC Nephrol 18:124","journal-title":"BMC Nephrol"},{"key":"5121_CR63","doi-asserted-by":"publisher","first-page":"e1001809","DOI":"10.1371\/journal.pmed.1001809","volume":"12","author":"A Mocroft","year":"2015","unstructured":"Mocroft A, Lundgren JD, Ross M, Law M et al (2015) Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med 12:e1001809. https:\/\/doi.org\/10.1371\/journal.pmed.1001809","journal-title":"PLoS Med"},{"key":"5121_CR64","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2215\/CJN.02730218","volume":"13","author":"SM Adams","year":"2018","unstructured":"Adams SM, Crisamore KR, Empey PE (2018) Clinical pharmacogenomics applications in nephrology. Clin J Am Soc Nephrol 13:1561\u20131571. https:\/\/doi.org\/10.2215\/CJN.02730218","journal-title":"Clin J Am Soc Nephrol"},{"key":"5121_CR65","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0956462418786562","volume":"29","author":"MI Danjuma","year":"2018","unstructured":"Danjuma MI, Egan D, Abubeker IY, Post F et al (2018) Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters. Int J STD AIDS 29:1384\u20131389. https:\/\/doi.org\/10.1177\/0956462418786562","journal-title":"Int J STD AIDS"},{"key":"5121_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00467-005-2105-4","volume":"21","author":"N Chen","year":"2006","unstructured":"Chen N, Aleksa K, Woodland C, Rieder M et al (2006) Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 21:160\u2013168","journal-title":"Pediatr Nephrol"},{"key":"5121_CR67","doi-asserted-by":"publisher","first-page":"4805853","DOI":"10.1155\/2019\/4805853","volume":"2019","author":"S Huang","year":"2019","unstructured":"Huang S, You J, Wang K, Li Y et al (2019) N-acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. Biomed Res Int 2019:4805853. https:\/\/doi.org\/10.1155\/2019\/4805853","journal-title":"Biomed Res Int"},{"key":"5121_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0091270010391790","volume":"52","author":"LN Hanly","year":"2012","unstructured":"Hanly LN, Chen N, Aleksa K, Cutler M et al (2012) N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics. J Clin Pharmacol 52:55\u201364. https:\/\/doi.org\/10.1177\/0091270010391790","journal-title":"J Clin Pharmacol"},{"key":"5121_CR69","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1681\/ASN.2017111197","volume":"29","author":"M Simons","year":"2018","unstructured":"Simons M (2018) The benefits of tubular proteinuria: an evolutionary perspective. J Am Soc Nephrol 29:710\u2013712","journal-title":"J Am Soc Nephrol"},{"key":"5121_CR70","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1046\/j.1523-1755.2001.00016.x","volume":"60","author":"AGW Norden","year":"2001","unstructured":"Norden AGW, Lapsley M, Lee PJ, Pusey CD et al (2001) Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60:1885\u20131892. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00016.x","journal-title":"Kidney Int"},{"key":"5121_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/QAI.0000000000001302","volume":"75","author":"KM Sheets","year":"2017","unstructured":"Sheets KM, Atta MG, Fine DM, Zook K et al (2017) Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications. J Acquir Immune Defic Syndr 75:45\u201351. https:\/\/doi.org\/10.1097\/QAI.0000000000001302","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5121_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ndt\/gfz081","volume":"35","author":"FX Lescure","year":"2020","unstructured":"Lescure FX, Fellahi S, Pialoux G, Bastard JP et al (2020) Prevalence of tubulopathy and association with renal function loss in HIV-infected patients. Nephrol Dial Transplant 35:607\u2013615. https:\/\/doi.org\/10.1093\/ndt\/gfz081","journal-title":"Nephrol Dial Transplant"},{"key":"5121_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa1307581","volume":"370","author":"ED Klootwijk","year":"2014","unstructured":"Klootwijk ED, Reichold M, Helip-Wooley A, Tolaymat A et al (2014) Mistargeting of peroxisomal EHHADH and inherited renal Fanconi\u2019s syndrome. N Engl J Med 370:129\u2013138. https:\/\/doi.org\/10.1056\/NEJMoa1307581","journal-title":"N Engl J Med"},{"key":"5121_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1172\/JCI129937","volume":"130","author":"M Bedin","year":"2020","unstructured":"Bedin M, Boyer O, Servais A, Li Y et al (2020) Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function. J Clin Invest 130:335\u2013344. https:\/\/doi.org\/10.1172\/JCI129937","journal-title":"J Clin Invest"},{"key":"5121_CR75","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","volume":"96","author":"A Nykjaer","year":"1999","unstructured":"Nykjaer A, Dragun D, Walther D, Vorum H et al (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507\u2013515. https:\/\/doi.org\/10.1016\/S0092-8674(00)80655-8","journal-title":"Cell"},{"key":"5121_CR76","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1517\/17425255.2010.497140","volume":"6","author":"J Nagai","year":"2010","unstructured":"Nagai J, Takano M (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin Drug Metab Toxicol 6:1125\u20131138","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5121_CR77","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2016060606","volume":"28","author":"Y Hori","year":"2017","unstructured":"Hori Y, Aoki N, Kuwahara S, Hosojima M et al (2017) Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J Am Soc Nephrol 28:1783\u20131791. https:\/\/doi.org\/10.1681\/ASN.2016060606","journal-title":"J Am Soc Nephrol"},{"key":"5121_CR78","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1517\/17425255.2015.1083011","volume":"11","author":"GC Gobe","year":"2015","unstructured":"Gobe GC, Coombes JS, Fassett RG, Endre ZH (2015) Biomarkers of drug-induced acute kidney injury in the adult. Expert Opin Drug Metab Toxicol 11:1683\u20131694","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5121_CR79","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/MNH.0000000000000538","volume":"28","author":"S Menez","year":"2019","unstructured":"Menez S, Parikh CR (2019) Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury. Curr Opin Nephrol Hypertens 28:560\u2013566. https:\/\/doi.org\/10.1097\/MNH.0000000000000538","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5121_CR80","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00204-019-02469-8","volume":"93","author":"PF Secker","year":"2019","unstructured":"Secker PF, Schlichenmaier N, Beilmann M, Deschl U et al (2019) Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC\/TERT1 cell line. Arch Toxicol 93:1965\u20131978. https:\/\/doi.org\/10.1007\/s00204-019-02469-8","journal-title":"Arch Toxicol"},{"key":"5121_CR81","first-page":"293","volume":"125","author":"JV Bonventre","year":"2014","unstructured":"Bonventre JV (2014) Kidney injury molecule-1: a translational journey. Trans Am Clin Climatol Assoc 125:293\u2013299","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"5121_CR82","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/toxsci\/kfx239","volume":"162","author":"Y Gebremichael","year":"2018","unstructured":"Gebremichael Y, Lu J, Shankaran H, Helmlinger G et al (2018) Multiscale mathematical model of drug-induced proximal tubule injury: linking urinary biomarkers to epithelial cell injury and renal dysfunction. Toxicol Sci 162:200\u2013211. https:\/\/doi.org\/10.1093\/toxsci\/kfx239","journal-title":"Toxicol Sci"},{"key":"5121_CR83","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.kint.2019.01.020","volume":"95","author":"Y Xie","year":"2019","unstructured":"Xie Y, Ankawi G, Yang B, Garzotto F et al (2019) Tissue inhibitor metalloproteinase-2 (TIMP-2)\u2022 IGF-binding protein-7 (IGFBP7)levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury. Kidney Int 95:1486\u20131493. https:\/\/doi.org\/10.1016\/j.kint.2019.01.020","journal-title":"Kidney Int"},{"key":"5121_CR84","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1681\/ASN.2018030265","volume":"29","author":"ACM Johnson","year":"2018","unstructured":"Johnson ACM, Zager RA (2018) Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. J Am Soc Nephrol 29:2157\u20132167. https:\/\/doi.org\/10.1681\/ASN.2018030265","journal-title":"J Am Soc Nephrol"},{"key":"5121_CR85","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1159\/000447937","volume":"41","author":"X Liu","year":"2016","unstructured":"Liu X, Guan Y, Xu S, Li Q et al (2016) Early predictors of acute kidney injury: a narrative review. Kidney Blood Press Res 41:680\u2013700","journal-title":"Kidney Blood Press Res"},{"key":"5121_CR86","doi-asserted-by":"publisher","unstructured":"Goldstein SL, Krallman KA, Schmerge A, Dill L et al (2021) Urinary neutrophil gelatinase-associated lipocalin rules out nephrotoxic acute kidney injury in children. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04898-5","DOI":"10.1007\/s00467-020-04898-5"},{"key":"5121_CR87","doi-asserted-by":"publisher","unstructured":"Assessment of a modified renal angina index for AKI prediction in critically ill adults. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfab049","DOI":"10.1093\/ndt\/gfab049"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05121-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05121-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05121-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T06:05:18Z","timestamp":1650521118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05121-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5121"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05121-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RJU is currently employed by AstraZeneca BioPharmaceuticals R&D, Early CVRM, Gothenburg, Sweden and Cambridge, UK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}